Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 5, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Eatable antibody factories to combat deadly gut infections!

CHOCOLATE & GREASY FOOD - MORE ACNE?

NIRRH Associate Jobs Recruitment | Online Applications Invited

Eatable antibody factories to combat deadly gut infections!
  • BiotechToday
  • World

Eatable antibody factories to combat deadly gut infections!

bioxone October 31, 2020October 31, 2020

Jayateerth S. Bhavikatti, CSIR-National Chemical Laboratory, Pune.

Clostridioides difficile (C. diff) is a causative agent for diarrhoea and colitis (colon inflammation) and its infection occurs usually during or soon after the administration of antibiotics. This happens as a result of wiping out the gut microbiome. In the US, nearly 30,000 people die annually from C. diff infection. Two major toxins of C. diff are TcdA and TcdB. One way to combat C. diff is through monoclonal antibodies against both these toxins. The procedure for producing monoclonal antibodies is quite tough. What if we had a better and a feasible alternative to fight C. diff infection?

A study lead by Hanping Feng, a microbiologist at the University of Maryland School of Dentistry has come up with a very feasible, easy and an inexpensive way to answer this puzzle. They have used a genetically modified strain of the yeast Saccharomyces boulardii, to be taken as a probiotic. The S. boulardii produces antibodies against the two toxins of C. diff in our gut. The results are very promising in mice model. So it is like eating the yeast that produces required antibodies against C. diff. Feng also says that the clinical trials would begin in about the next three months. Although the challenge is, getting approval from the US-FDA for administering genetically modified yeast, which is the first of its kind. Let us hope for the best.

Also read: WILL COVID-19 VACCINE WORK?

References:

  1. Di Bella S, Ascenzi P, Siarakas S, Petrosillo N, di Masi A. Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects. Toxins (Basel). 2016 May 3;8(5):134. https://dx.doi.org/10.3390/toxins8050134. PMID: 27153087; PMCID: PMC4885049.
  2. https://www.cdc.gov/cdiff/index.html
  3. https://www.sciencemag.org/news/2020/10/antibody-producing-yeast-vanquishes-deadly-gut-infection-mice
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged C. diff colitis gut infection diarrhoea gut microbiome S. boulardii

2 thoughts on “Eatable antibody factories to combat deadly gut infections!”

  1. Pingback: Covid updates- Quantification of antibody through plasmonic substrates for SARS-CoV-2 Detection - BioXone
  2. Pingback: Barriers to developing clinical trials in Lewy body dementia - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

NIRRH Associate Jobs Recruitment | Online Applications Invited

bioxone October 31, 2020

-Shristi Sharma, Team bioXone NIRRH Associate Jobs Recruitment – Online Applications Invited. NIRRH recruitment for Natural Sciences/ Molecular Biology candidates. NIRRH National Institute for Research in Reproductive Health latest job details, walk-in details, check out all of the information on the same below: NIRRH Job Details Designation: Project Associate-II Vacancies: 01 Project Title: “Omics of […]

Related Post

  • BiotechToday
  • World

Evotype: a novel concept to understand the engineering aspect of evolution

BioTech Today June 12, 2021June 12, 2021

Ayooshi Mitra, Amity University Kolkata The world has seen a revolution in the ability to engineer biology and create living systems with novel functions over the last few decades. Nonetheless, several obstacles continue to obstruct our ability to fully exploit biology’s potential. These are a consequence of the fact that individuals cannot engineer the elements […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Can the COVID-19 vaccine integrate with the human genome?

bioxone July 14, 2021July 14, 2021

Madhavi Bhatia, NIPER Guwahati SARS-CoV-19, well known as a severe acute respiratory syndrome that affects mainly the respiratory system of humans has become a global pandemic. Various vaccines have been approved worldwide to curb the disease. In Australia, the Pfizer and Moderna vaccine is approved. Both these vaccines are a type of encapsulated mRNA vaccine, […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • FEATURED
  • Latest
  • World

COVID UPDATE: Coronavirus was fabricated in government-controlled Wuhan lab, claims Chinese virologist, Dr. Li-Meng Yan

bioxone September 14, 2020September 14, 2020

–Sagnik Nag, Amity University Kolkata The emergence of an exceedingly pathogenic human Coronavirus in the Middle East has sparked novel concern in human coronaviruses around the world. The coronavirus came into view in Wuhan, a city of 10.9 million people in China’s Hubei zone’19. The highly contagious novel SARS-COV-2 virus not only affected the medical […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy